Merus

Merus works on clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer. Utilizing their proprietary technology platforms, they are developing innovative multispecific antibody therapeutics, referred to as Multiclonics.

For more information, click here.

Title

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. Settings Ok

Tracking Cookies

We use cookies to analyze user activity in order to improve the website. We can use such analysis to gain insights about how to improve the functionality and user experience of the website.

Third Party Embeds

We use cookies, web beacons, and other storage technologies from third-party partners such as Google for measurement services, better targeting ads, and for marketing purposes. These cookies, web beacons, and other storage technologies allow us to display promotional material to you on other sites you visit across the Internet. We may also share information about your behavior on the website with third parties (including operators of third-party websites) in order to show you targeted advertisements and other content that has been customized for you. You have a right to object to the legitimate interest use of your Personal Data for the purposes of marketing.

YouTube
Facebook
Twitter
Google Maps